Tag: SDX
KemPharm Announces Serdexmethylphenidate (SDX) Has Been Classified as a Schedule IV...
KP879, KemPharm’s Lead Product Candidate Based on SDX and Intended for the Treatment of Stimulant Use Disorder (SUD), Could Be Schedule IV, If...